Sequencing and Second-Line Therapy in RCC: Patient Scenario

Expert oncologists discuss the challenges and considerations in choosing second-line therapy for a patient with metastatic renal cell carcinoma (RCC) in a case-based context.

Related Keywords

, Optimizing Therapy , Advanced Renal Cell Carcinoma , Second Line Therapy , Patient Scenario , Renal Cell Carcinoma , Metastatic Rcc , Kidney Cancer , Sequencing , Case Based Discussion , Adjuvant Therapy , Immune Therapy , Metastatic Kidney Cancer , Treatment Choice , Pembrolizumab , Clinical Trial , Tki Based Therapy , Adjuvant Treatment , Risk Factors , Quality Of Life , Therapy Sequence , Progression , Cabozantinib , Axitinib , Everolimus , Drug Interaction ,